Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

CSL Ltd

CSLLY
Current price
88.73 USD +1.73 USD (+1.99%)
Last closed 271.36 AUD
ISIN AU000000CSL8
Sector Healthcare
Industry Biotechnology
Exchange AU
Capitalization 133 793 775 095 AUD
Yield for 12 month +6.81 %
1Y
3Y
5Y
10Y
15Y
CSLLY
21.11.2021 - 28.11.2021

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants. The CSL Seqirus segment provides influenza related products and pandemic services to governments. The CSL Vifor segment offers products in the therapeutic areas of iron deficiency and nephrology. The company also licenses CSL intellectual property. CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia. Address: 655 Elizabeth Street, Melbourne, VIC, Australia, 3000

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

330.2 AUD

P/E ratio

32.1136

Dividend Yield

1.48 %

Current Year

+34 356 157 222 AUD

Last Year

+30 015 448 353 AUD

Current Quarter

+15 543 179 550 AUD

Last Quarter

+18 825 984 211 AUD

Current Year

+23 430 601 143 AUD

Last Year

+14 506 479 403 AUD

Current Quarter

+7 078 841 324 AUD

Last Quarter

+9 656 097 455 AUD

Key Figures CSLLY

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 4 624 922 690 AUD
Operating Margin TTM 19.02 %
PE Ratio 32.1136
Return On Assets TTM 6.56 %
PEG Ratio
Return On Equity TTM 14.58 %
Wall Street Target Price 330.2 AUD
Revenue TTM 14 822 186 600 AUD
Book Value 35.98 AUD
Revenue Per Share TTM
Dividend Share 2.64 AUD
Quarterly Revenue Growth YOY 10.1 %
Dividend Yield 1.48 %
Gross Profit TTM 6 854 259 803 AUD
Earnings per share 8.46 AUD
Diluted Eps TTM 8.46 AUD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY 30.7 %
Profit Margin 17.85 %

Dividend Analytics CSLLY

Dividend growth over 5 years

59 %

Continuous growth

2 years

Payout Ratio 5 years average

67 %

Dividend History CSLLY

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 3.97
Ex Dividend Date 09.09.2024
Forward Annual Dividend Yield 1.46 %
Last Split Factor 3:1
Payout Ratio 45.18 %
Last Split Date 18.10.2007
Dividend Date

Stock Valuation CSLLY

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 32.1136
Forward PE 32.1543
Enterprise Value Revenue 6.517
Price Sales TTM 9.0266
Enterprise Value EBITDA 20.227
Price Book MRQ 4.9075

Financials CSLLY

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators CSLLY

For 52 weeks

253.07 AUD 311.74 AUD
50 Day MA 291.68 AUD
Shares Short Prior Month
200 Day MA 290.81 AUD
Short Ratio
Shares Short
Short Percent